NOV 19, 2020 7:00 AM PST

Parasitic Worms Help Unravel the Immune Mechanisms Underlying Chronic Disease

WRITTEN BY: Tara Fernandez

Parasitic worms known as helminths have a complicated relationship with the immune systems of the hosts they invade. Termed by experts as “masters of immunomodulation”, worms are able to tinker with inflammatory pathways on a molecular level to keep immune attacks at bay. By putting the molecular mechanisms of worm infections under the microscope, researchers have gained new insights into the nature of an immune regulator known as IL-33.

"The mantra of my lab since its inception has been that parasitic worms manipulate their hosts in very interesting ways to maintain their survival," said Penn University’s De'Broski Herbert, the lead author of a study published in Science Immunology detailing these newly discovered immune pathways.  "SARS-CoV-2 doesn't care about staying in your body very long because it is transmitted so easily. Worms aren't spread so easily, so they have to figure out how to persist."

Helminth parasites are of considerable medical and economic importance due to their ability to infect both humans and animals with potentially lethal consequences. For the most part, however, helminths are able to remain in stealth mode after infecting their host, staying just out of reach of the host’s immune defenses. One of the ways they achieve this is through the modulation of IL-33.

The cytokine IL-33 is not only relevant for parasitic infections but has been shown to play a role in an array of other chronic conditions including asthma and obesity. In their study, Herbert and colleagues discovered that IL-33 has two distinct functions: it can either suppress or activate the immune system. The team identified that its functionality depends on which cell is releasing IL-33.

The scientists used a genetically-engineered mouse model wherein specific cells were modified to disrupt their production of IL-33. The mice were then exposed to hookworms, an intestinal, blood-feeding parasitic roundworm. Mice with immune cells that were not able to secrete IL-33 eliminated the hookworms from their systems rapidly. However, those with immune cells that could produce IL-33 ended up with persistent infections.

The study opens up a whole new field of translational immunology.  "It's kind of the missing link," said Herbert. "It opens up a whole new direction for understanding how this cytokine could be involved in obesity, inflammatory bowel disease, Crohn's, asthma, and development."

 

 

Sources: Eurekalert, Science Immunology


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
NOV 12, 2020
Health & Medicine
Measles Cases and Deaths Surge Worldwide
NOV 12, 2020
Measles Cases and Deaths Surge Worldwide
Today, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) released a stat ...
DEC 28, 2020
Immunology
Inhaling a Puff of Llama Antibodies to Relieve COVID
DEC 28, 2020
Inhaling a Puff of Llama Antibodies to Relieve COVID
Scientists at the National Institutes of Health have identified new antibody-based weapons in the fight against COVID-19 ...
FEB 07, 2021
Microbiology
Positive Results From A Clinical Trial of an HIV Vaccine
FEB 07, 2021
Positive Results From A Clinical Trial of an HIV Vaccine
After years of effort, researchers are reporting that there were encouraging results from a phase 1 clinical trial which ...
FEB 10, 2021
Immunology
Cross-Reactive Antibodies Don't Protect Against COVID
FEB 10, 2021
Cross-Reactive Antibodies Don't Protect Against COVID
Did you know that hundreds of viruses can cause the common cold? Rhinovirus, adenovirus, and coronavirus infections can ...
Loading Comments...